Cart
sales@molnova.com
Antineoplaston A10
CAS No. 77658-84-5
Antineoplaston A10( —— )
Catalog No. M20127 CAS No. 77658-84-5
Antineoplaston A10 is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It displayed anti-proliferative action inhibiting cell growth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | In Stock |
|
| 5MG | 120 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 491 | In Stock |
|
| 100MG | 708 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAntineoplaston A10
-
NoteResearch use only not for human use.
-
Brief DescriptionAntineoplaston A10 is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It displayed anti-proliferative action inhibiting cell growth.
-
DescriptionAntineoplaston A10 is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It displayed anti-proliferative action inhibiting cell growth.
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77658-84-5
-
Formula Weight246.26
-
Molecular FormulaC13H14N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(Cc1ccccc1)NC1CCC(=O)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tsuda H et al. Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma. Kurume Med J. 1996;43(2):137-47.
molnova catalog
related products
-
Compound 3344
3344 is an inhibitor of KRAS-effector interactions，with an affnity of 126nm.
-
Deltasonamide 2
Deltasonamide 2 (Deltasonamide-2) isa novel small molecule inhibitor of PDE6δ/KRas interaction with Kd of 385 pM.
-
ARS-1620
ARS-1620 is a potent, specific and covalent KRAS G12C inhibitor.
